\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ physical\\ exam\\ patient\\ has\\ an\\ enlarged\\,\\ nontender\\ thyroid\\ gland\\ without\\ palpable\\ nodules\\.\\ \\ labs\\ were\\ significant\\ for\\ tsh\\ \\<0\\.08\\ \\Â\\µiu\\/ml\\ \\(normal\\ 0\\.5\\-5\\.0\\ \\Â\\µiu\\/ml\\)\\,\\ free\\ t4\\ of\\ 5\\.88\\ \\(normal\\ 0\\.71\\-1\\.85\\)\\,\\ and\\ t3\\ of\\ 510\\.55\\ \\(normal\\ 59\\.00\\-174\\.00\\)\\.\ \(0\)\
\-\ patients\\ was\\ treated\\ with\\ \\ radioiodine\\ ablation\\ using\\ 15\\ mci\\ of\\ \\ i\\-131\\.\ \(0\)\
\-\ thyroid\\ uptake\\ using\\ 7\\Â\\µci\\ of\\ i\\-131\\ and\\ thyroid\\ scan\\ using\\ 10\\ mci\\ tc\\-99m\\.\\ \\ the\\ 24\\ hour\\ radioiodine\\ uptake\\ was\\ determined\\ to\\ be\\ 89\\.4\\%\\ \\(normal\\ range\\,\\ 8\\-30\\%\\)\\.\\ \\ the\\ planar\\ and\\ pinhole\\ scan\\ of\\ the\\ neck\\ shows\\ diffuse\\,\\ homogenous\\ uptake\\,\\ right\\ greater\\ than\\ left\\,\\ in\\ an\\ enlarged\\ thyroid\\ gland\\.\\ \\ the\\ pyramidal\\ lobe\\ is\\ visible\\.\ \(0\)\
\-\ graves\\'\\ disease\ \(0\)\
\-\ graves\\'\\ disease\ \(0\)\
\-\ 17\\-year\\ old\\ white\\ male\\ with\\ three\\ to\\ four\\-month\\ history\\ of\\ proptosis\\,\\ tachycardia\\,\\ heat\\ intolerance\\ and\\ weight\\ loss\\.\\ \\ patient\\ placed\\ on\\ atenolol\\ for\\ control\\ of\\ heart\\ rate\\.\ \(0\)\
\-\ graves\\â\\€\\™\\ disease\\ is\\ the\\ most\\ common\\ cause\\ of\\ thyrotoxicosis\\.\\ \\ the\\ peak\\ incidence\\ is\\ in\\ the\\ third\\ and\\ fourth\\ decades\\ with\\ a\\ female\\ predominance\\ of\\ 5\\:1\\.\\ \\ it\\ is\\ an\\ autoimmune\\ disorder\\ characterized\\ by\\ circulating\\ thyroid\\ stimulating\\ immunoglobulins\\,\\ which\\ bind\\ to\\ the\\ thyroid\\ stimulating\\ receptors\\ of\\ the\\ thyroid\\ cells\\ causing\\ thyroid\\ gland\\ hypertrophy\\ and\\ increased\\ synthesis\\ and\\ secretion\\ of\\ thyroid\\ hormone\\.\\ \\ symptoms\\ include\\ tachycardia\\,\\ heat\\ intolerance\\,\\ weight\\ loss\\,\\ diarrhea\\,\\ agitation\\ or\\ nervousness\\,\\ tremor\\ and\\ weakness\\.\\ \\ this\\ patient\\ was\\ atypical\\ based\\ on\\ the\\ fact\\ that\\ he\\ was\\ a\\ young\\ male\\.\\ \ \(0\)\
\-\ laboratory\\ findings\\ in\\ graves\\â\\€\\™\\ disease\\ include\\ suppressed\\ tsh\\ and\\ elevated\\ levels\\ of\\ free\\ t4\\ and\\ t3\\.\\ \\ the\\ 24\\-hour\\ radioiodine\\ uptake\\ will\\ be\\ increased\\ above\\ 30\\%\\.\\ \\ thyroid\\ scans\\ using\\ tc99m\\ show\\ diffuse\\,\\ homogenous\\ uptake\\ within\\ an\\ enlarged\\ gland\\.\\ \\ \\ this\\ patient\\ had\\ the\\ classic\\ signs\\ and\\ symptoms\\ of\\ hyperthyroidism\\ including\\ a\\ diffuse\\ homogenous\\ uptake\\ greater\\ than\\ 80\\%\\ on\\ his\\ nuclear\\ medicine\\ study\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.10776345984383726\ \(0\)\
\-\ graves\\:\\ 0\\.06584347718359103\ \(0\)\
\-\ radioiodine\\:\\ 0\\.06341176869148786\ \(0\)\
\-\ uptake\\:\\ 0\\.06267661707127777\ \(0\)\
\-\ \\Â\\µiu\\/ml\\:\\ 0\\.054249344147486146\ \(0\)\
\-\ homogenous\\:\\ 0\\.046872450513998125\ \(0\)\
\-\ using\\:\\ 0\\.045656282462349755\ \(0\)\
\-\ gland\\:\\ 0\\.044792230047909776\ \(0\)\
\-\ stimulating\\:\\ 0\\.04007958972906125\ \(0\)\
\-\ i\\-131\\:\\ 0\\.036462441021971284\ \(0\)\
\-\ mci\\:\\ 0\\.03419951929812318\ \(0\)\
\-\ t3\\:\\ 0\\.03396727112592104\ \(0\)\
\-\ heat\\:\\ 0\\.032921738591795514\ \(0\)\
\-\ intolerance\\:\\ 0\\.032732374538461645\ \(0\)\
\-\ t4\\:\\ 0\\.030823728825822638\ \(0\)\
\-\ tachycardia\\:\\ 0\\.02993399818698505\ \(0\)\
\-\ tsh\\:\\ 0\\.028560807101974527\ \(0\)\
\-\ 0\\.5\\-5\\.0\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 5\\.88\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 510\\.55\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 59\\.00\\-174\\.00\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 7\\Â\\µci\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 89\\.4\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ 17\\-year\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ four\\-month\\:\\ 0\\.027124672073743073\ \(0\)\
\-\ enlarged\\:\\ 0\\.026913425265083137\ \(0\)\
\-\ \\'\\:\\ 0\\.02669650221223564\ \(0\)\
\-\ \\%\\:\\ 0\\.02453318194887394\ \(0\)\
\-\ diffuse\\:\\ 0\\.02388006849577214\ \(0\)\
\-\ 5\\:1\\.\\:\\ 0\\.023744326570148886\ \(0\)\
\-\ bind\\:\\ 0\\.022859150962604945\ \(0\)\
\-\ receptors\\:\\ 0\\.022859150962604945\ \(0\)\
\-\ synthesis\\:\\ 0\\.022172555420099684\ \(0\)\
\-\ free\\:\\ 0\\.021644314199498225\ \(0\)\
\-\ atenolol\\:\\ 0\\.021611566014579826\ \(0\)\
\-\ 0\\.71\\-1\\.85\\:\\ 0\\.021137256230495952\ \(0\)\
\-\ circulating\\:\\ 0\\.021137256230495952\ \(0\)\
\-\ immunoglobulins\\:\\ 0\\.021137256230495952\ \(0\)\
\-\ agitation\\:\\ 0\\.020726390407035885\ \(0\)\
\-\ pinhole\\:\\ 0\\.020363981066554702\ \(0\)\
\-\ nervousness\\:\\ 0\\.020363981066554702\ \(0\)\
\-\ 0\\.08\\:\\ 0\\.020039794864530624\ \(0\)\
\-\ 8\\-30\\:\\ 0\\.020039794864530624\ \(0\)\
\-\ pyramidal\\:\\ 0\\.020039794864530624\ \(0\)\
\-\ greater\\:\\ 0\\.019752100662587698\ \(0\)\
\-\ secretion\\:\\ 0\\.019478805459010762\ \(0\)\
\-\ 24\\-hour\\:\\ 0\\.019478805459010762\ \(0\)\
\-\ thyrotoxicosis\\:\\ 0\\.01923252020463065\ \(0\)\
\-\ weight\\:\\ 0\\.018848897139328403\ \(0\)\
\-\ tc99m\\:\\ 0\\.0187922099165055\ \(0\)\
\-\ tremor\\:\\ 0\\.0184070925535701\ \(0\)\
\-\ suppressed\\:\\ 0\\.01775691072690177\ \(0\)\
\-\ disease\\:\\ 0\\.01719061589188559\ \(0\)\
\-\ planar\\:\\ 0\\.01709975964906159\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.01698363556296052\ \(0\)\
\-\ decades\\:\\ 0\\.016871735119357828\ \(0\)\
\-\ autoimmune\\:\\ 0\\.01676376182763084\ \(0\)\
\-\ normal\\:\\ 0\\.016487537902758167\ \(0\)\
\-\ ablation\\:\\ 0\\.016460869295897757\ \(0\)\
\-\ predominance\\:\\ 0\\.016460869295897757\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.01571708762858742\ \(0\)\
\-\ loss\\:\\ 0\\.01526439490749809\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.015026747049975914\ \(0\)\
\-\ peak\\:\\ 0\\.014966999093492524\ \(0\)\
\-\ hormone\\:\\ 0\\.014908389262813466\ \(0\)\
\-\ include\\:\\ 0\\.014751713772494072\ \(0\)\
\-\ scan\\:\\ 0\\.014721670525741406\ \(0\)\
\-\ proptosis\\:\\ 0\\.014684514326559841\ \(0\)\
\-\ an\\:\\ 0\\.014543567560427444\ \(0\)\
\-\ hour\\:\\ 0\\.014376565223307587\ \(0\)\
\-\ fact\\:\\ 0\\.013840093262862117\ \(0\)\
\-\ than\\:\\ 0\\.013778762184112454\ \(0\)\
\-\ determined\\:\\ 0\\.013719414145467405\ \(0\)\
\-\ diarrhea\\:\\ 0\\.013641513197823434\ \(0\)\
\-\ nuclear\\:\\ 0\\.0135655359283146\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.013528239434368924\ \(0\)\
\-\ nontender\\:\\ 0\\.013491389615763643\ \(0\)\
\-\ \\,\\:\\ 0\\.013327264763927994\ \(0\)\
\-\ symptoms\\:\\ 0\\.013105584473219318\ \(0\)\
\-\ characterized\\:\\ 0\\.013080523792303575\ \(0\)\
\-\ increased\\:\\ 0\\.012864521734151728\ \(0\)\
\-\ fourth\\:\\ 0\\.012718114451822395\ \(0\)\
\-\ medicine\\:\\ 0\\.012471829197442283\ \(0\)\
\-\ visible\\:\\ 0\\.012445642460002564\ \(0\)\
\-\ 80\\:\\ 0\\.012368393471906944\ \(0\)\
\-\ scans\\:\\ 0\\.012243804667738525\ \(0\)\
\-\ was\\:\\ 0\\.012163415658014607\ \(0\)\
\-\ incidence\\:\\ 0\\.012054395766201806\ \(0\)\
\-\ control\\:\\ 0\\.011986269225041148\ \(0\)\
\-\ disorder\\:\\ 0\\.011811645173987457\ \(0\)\
\-\ young\\:\\ 0\\.011451594532799187\ \(0\)\
\-\ atypical\\:\\ 0\\.011395478878799862\ \(0\)\
\-\ causing\\:\\ 0\\.011358629060194582\ \(0\)\
\-\ nodules\\:\\ 0\\.010900058047393081\ \(0\)\
\-\ levels\\:\\ 0\\.010853081210067578\ \(0\)\
\-\ placed\\:\\ 0\\.01064286815167534\ \(0\)\
\-\ range\\:\\ 0\\.010585353896253332\ \(0\)\
\-\ third\\:\\ 0\\.010542912905076914\ \(0\)\
\-\ cells\\:\\ 0\\.010542912905076914\ \(0\)\
\-\ patient\\:\\ 0\\.010542669918970928\ \(0\)\
\-\ 15\\:\\ 0\\.0104872204692504\ \(0\)\
\-\ rate\\:\\ 0\\.010248373816848748\ \(0\)\
\-\ 24\\:\\ 0\\.010222944555772153\ \(0\)\
\-\ \\<\\:\\ 0\\.01014789393077474\ \(0\)\
\-\ 30\\:\\ 0\\.01011104411216946\ \(0\)\
\-\ classic\\:\\ 0\\.010074630396332529\ \(0\)\
\-\ based\\:\\ 0\\.010026739576206032\ \(0\)\
\-\ weakness\\:\\ 0\\.009764958009318106\ \(0\)\
\-\ laboratory\\:\\ 0\\.009689513033397126\ \(0\)\
\-\ above\\:\\ 0\\.00963673432808559\ \(0\)\
\-\ male\\:\\ 0\\.009508957156230603\ \(0\)\
\-\ including\\:\\ 0\\.009493595818439766\ \(0\)\
\-\ palpable\\:\\ 0\\.009318833977230125\ \(0\)\
\-\ signs\\:\\ 0\\.009253464412264783\ \(0\)\
\-\ labs\\:\\ 0\\.00914453540595427\ \(0\)\
\-\ heart\\:\\ 0\\.009135629688950073\ \(0\)\
\-\ elevated\\:\\ 0\\.008920973419566347\ \(0\)\
\-\ on\\:\\ 0\\.008909427844497577\ \(0\)\
\-\ cause\\:\\ 0\\.008896192697082972\ \(0\)\
\-\ \\(\\:\\ 0\\.008890605861462899\ \(0\)\
\-\ 10\\:\\ 0\\.00886345916414434\ \(0\)\
\-\ three\\:\\ 0\\.00886345916414434\ \(0\)\
\-\ \\)\\:\\ 0\\.008782002364471447\ \(0\)\
\-\ white\\:\\ 0\\.008720320654498516\ \(0\)\
\-\ study\\:\\ 0\\.008651173405722952\ \(0\)\
\-\ will\\:\\ 0\\.00822609544116659\ \(0\)\
\-\ be\\:\\ 0\\.008109272143654948\ \(0\)\
\-\ show\\:\\ 0\\.008071249029205004\ \(0\)\
\-\ treated\\:\\ 0\\.007870310264873413\ \(0\)\
\-\ neck\\:\\ 0\\.007720748113903023\ \(0\)\
\-\ his\\:\\ 0\\.007578120085067483\ \(0\)\
\-\ he\\:\\ 0\\.007335961052409291\ \(0\)\
\-\ shows\\:\\ 0\\.007228842153011935\ \(0\)\
\-\ lobe\\:\\ 0\\.007074847224380104\ \(0\)\
\-\ significant\\:\\ 0\\.007070298926320687\ \(0\)\
\-\ is\\:\\ 0\\.006920501887812008\ \(0\)\
\-\ common\\:\\ 0\\.006880822190635068\ \(0\)\
\-\ patients\\:\\ 0\\.0068048449211262334\ \(0\)\
\-\ physical\\:\\ 0\\.006450785444865348\ \(0\)\
\-\ without\\:\\ 0\\.006190809742640493\ \(0\)\
\-\ and\\:\\ 0\\.0060926125017058555\ \(0\)\
\-\ most\\:\\ 0\\.006070261974547926\ \(0\)\
\-\ were\\:\\ 0\\.005970111805199758\ \(0\)\
\-\ this\\:\\ 0\\.005914690543471588\ \(0\)\
\-\ it\\:\\ 0\\.005910302721640052\ \(0\)\
\-\ exam\\:\\ 0\\.0057761044306139635\ \(0\)\
\-\ had\\:\\ 0\\.005673384059202179\ \(0\)\
\-\ findings\\:\\ 0\\.005596421340892183\ \(0\)\
\-\ female\\:\\ 0\\.005405416219839488\ \(0\)\
\-\ the\\:\\ 0\\.005104588973672337\ \(0\)\
\-\ within\\:\\ 0\\.0050157889488802515\ \(0\)\
\-\ has\\:\\ 0\\.004937538370751625\ \(0\)\
\-\ which\\:\\ 0\\.004908137191515534\ \(0\)\
\-\ of\\:\\ 0\\.004660152031919537\ \(0\)\
\-\ that\\:\\ 0\\.00454147916479638\ \(0\)\
\-\ for\\:\\ 0\\.004486819376262862\ \(0\)\
\-\ by\\:\\ 0\\.004378064317676538\ \(0\)\
\-\ to\\:\\ 0\\.003942167154858335\ \(0\)\
\-\ in\\:\\ 0\\.0038898205859100457\ \(0\)\
\-\ a\\:\\ 0\\.0036609212475563198\ \(0\)\
\-\ history\\:\\ 0\\.003631429346791026\ \(0\)\
\-\ or\\:\\ 0\\.0030816084583498693\ \(0\)\
\-\ left\\:\\ 0\\.002941862366993584\ \(0\)\
\-\ right\\:\\ 0\\.002774251412647436\ \(0\)\
\-\ old\\:\\ 0\\.0026921064518838603\ \(0\)\
\-\ \\.\\:\\ 0\\.001856898811245805\ \(0\)\
\-\ with\\:\\ 0\\.0010800385485220591\ \(0\)\
